SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma submits annual report

20 Jun 2019 Evaluate

Ajanta Pharma has informed about submission of Annual Report for financial year 2018-19 under Regulation 34(1). 

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

3387.20 20.75 (0.62%)
27-Jul-2026 11:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1959.00
Dr. Reddys Labs. 1152.00
Cipla 1409.60
Lupin 2414.40
Zydus Lifesciences 1108.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: